Descriptor English: | Estrogens, Conjugated (USP) | ||||||
Descriptor Spanish: |
Estrógenos Conjugados (USP)
| ||||||
Descriptor Portuguese: | Estrogênios Conjugados (USP) | ||||||
Descriptor French: | Oestrogènes conjugués (USP) | ||||||
Entry term(s): |
Carentil Climarest Climopax Congest Conjugated Equine Estrogen Conjugated Equine Estrogens Conjugated Estrogen Conjugated Estrogenic Hormones Conjugated Estrogenic Substances Conjugated Estrogens Dagynil Equine Estrogen, Conjugated Equine Estrogens, Conjugated Estro Feminal Estro-Feminal Estrogen, Conjugated Estrogen, Conjugated Equine Estrogenic Hormones, Conjugated Estrogenic Substances, Conjugated Estrogens, Conjugated Femavit Oestro Feminal Oestro-Feminal Oestrofeminal Prelestrin Premarin Presomen Progen Progens Transannon |
||||||
Tree number(s): |
D06.472.334.851.437.988 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004966 | ||||||
Scope note: | A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. |
||||||
Annotation: | do not confuse with ESTRADIOL CONGENERS |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Estrogens |
||||||
Public MeSH Note: | 2004; see ESTROGENS, CONJUGATED 1994-2003, see ESTROGENIC SUBSTANCES, CONJUGATED 1973-1993; CENESTIN was indexed under ESTROGENS, CONJUGATED 1999-2002; PRESOMEN was indexed under ESTROGENIC SUBSTANCES, CONJUGATED 1987-1998; for PREMARIN see PREMARIN 1991-1993, see ESTROGENIC SUBSTANCES, CONJUGATED 1975-1990 |
||||||
History Note: | 2004 (1973); for CENESTIN use ESTROGENS, CONJUGATED (NM) 1999-2002 |
||||||
DeCS ID: | 31834 | ||||||
Unique ID: | D004966 | ||||||
NLM Classification: | WP 522 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2004/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2020/05/27 |
|
Estrogens, Conjugated (USP)
- Preferred
Congest
- Narrower
Conjugated Equine Estrogens
- Narrower
Dagynil
- Narrower
Oestrofeminal
- Narrower
Premarin
- Narrower
Presomen
- Narrower
Progens
- Narrower
Transannon
- Narrower
Carentil
- Narrower
Prelestrin
- Narrower
Concept UI |
M0007792 |
Scope note | A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. |
Preferred term | Estrogens, Conjugated (USP) |
Entry term(s) |
Conjugated Estrogen Conjugated Estrogenic Hormones Conjugated Estrogenic Substances Conjugated Estrogens Estrogen, Conjugated Estrogenic Hormones, Conjugated Estrogenic Substances, Conjugated Estrogens, Conjugated |
Concept UI |
M0485329 |
Preferred term | Congest |
Concept UI |
M0405163 |
Preferred term | Conjugated Equine Estrogens |
Entry term(s) |
Conjugated Equine Estrogen Equine Estrogen, Conjugated Equine Estrogens, Conjugated Estrogen, Conjugated Equine |
Concept UI |
M0485328 |
Preferred term | Dagynil |
Concept UI |
M0492519 |
Preferred term | Oestrofeminal |
Entry term(s) |
Estro Feminal Estro-Feminal Oestro Feminal Oestro-Feminal |
Concept UI |
M0007793 |
Preferred term | Premarin |
Entry term(s) |
Climarest Climopax |
Concept UI |
M0007794 |
Preferred term | Presomen |
Concept UI |
M0492517 |
Preferred term | Progens |
Entry term(s) |
Progen |
Concept UI |
M0492516 |
Preferred term | Transannon |
Entry term(s) |
Femavit |
Concept UI |
M0485330 |
Preferred term | Carentil |
Concept UI |
M0492518 |
Preferred term | Prelestrin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey